Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics

Publikation: Bidrag til bog/antologi/rapport/proceedingBidrag til bog/antologiForskningpeer review

Standard

Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics. / Howard, Ken.

Nanotechnology for the Delivery of Therapeutic Nucleic Acids. Pan Stanford Publishing, 2013. s. 129-151.

Publikation: Bidrag til bog/antologi/rapport/proceedingBidrag til bog/antologiForskningpeer review

Harvard

Howard, K 2013, Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics. i Nanotechnology for the Delivery of Therapeutic Nucleic Acids. Pan Stanford Publishing, s. 129-151. https://doi.org/10.4032/9789814411059

APA

Howard, K. (2013). Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics. I Nanotechnology for the Delivery of Therapeutic Nucleic Acids (s. 129-151). Pan Stanford Publishing. https://doi.org/10.4032/9789814411059

CBE

Howard K. 2013. Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics. I Nanotechnology for the Delivery of Therapeutic Nucleic Acids. Pan Stanford Publishing. s. 129-151. https://doi.org/10.4032/9789814411059

MLA

Howard, Ken "Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics". Nanotechnology for the Delivery of Therapeutic Nucleic Acids. Kapitel B, Pan Stanford Publishing. 2013, 129-151. https://doi.org/10.4032/9789814411059

Vancouver

Howard K. Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics. I Nanotechnology for the Delivery of Therapeutic Nucleic Acids. Pan Stanford Publishing. 2013. s. 129-151 https://doi.org/10.4032/9789814411059

Author

Howard, Ken. / Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics. Nanotechnology for the Delivery of Therapeutic Nucleic Acids. Pan Stanford Publishing, 2013. s. 129-151

Bibtex

@inbook{f5cc86255eb5436ba6c94970afc0a05c,
title = "Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics",
abstract = "The process of RNA interference (RNAi) by which cellular gene expression is controlled through the specific action of small interfering RNA (siRNA) is set to revolutionalise disease treatment. A greater understanding of the RNA pathway has resulted in an expanding repertoire of potential RNAi-based drugs whose action is dependent on intracellular target interaction. This work describes the use of polymeric nanoparticles used to overcome intracellular barriers and facilitate interaction of RNAi triggers with the RNAi machinery. Focus will be given to bioresponsive nanoparticles based on copolypeptides and hyperbranched polymers for controlling the intracellular spatial and temporal efects of synthetic microRNA and siRNA.",
author = "Ken Howard",
year = "2013",
month = mar,
day = "31",
doi = "10.4032/9789814411059",
language = "English",
isbn = "9789814411042",
pages = "129--151",
booktitle = "Nanotechnology for the Delivery of Therapeutic Nucleic Acids",
publisher = "Pan Stanford Publishing",

}

RIS

TY - CHAP

T1 - Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics

AU - Howard, Ken

PY - 2013/3/31

Y1 - 2013/3/31

N2 - The process of RNA interference (RNAi) by which cellular gene expression is controlled through the specific action of small interfering RNA (siRNA) is set to revolutionalise disease treatment. A greater understanding of the RNA pathway has resulted in an expanding repertoire of potential RNAi-based drugs whose action is dependent on intracellular target interaction. This work describes the use of polymeric nanoparticles used to overcome intracellular barriers and facilitate interaction of RNAi triggers with the RNAi machinery. Focus will be given to bioresponsive nanoparticles based on copolypeptides and hyperbranched polymers for controlling the intracellular spatial and temporal efects of synthetic microRNA and siRNA.

AB - The process of RNA interference (RNAi) by which cellular gene expression is controlled through the specific action of small interfering RNA (siRNA) is set to revolutionalise disease treatment. A greater understanding of the RNA pathway has resulted in an expanding repertoire of potential RNAi-based drugs whose action is dependent on intracellular target interaction. This work describes the use of polymeric nanoparticles used to overcome intracellular barriers and facilitate interaction of RNAi triggers with the RNAi machinery. Focus will be given to bioresponsive nanoparticles based on copolypeptides and hyperbranched polymers for controlling the intracellular spatial and temporal efects of synthetic microRNA and siRNA.

UR - http://www.scopus.com/inward/record.url?scp=84882008631&partnerID=8YFLogxK

U2 - 10.4032/9789814411059

DO - 10.4032/9789814411059

M3 - Book chapter

AN - SCOPUS:84882008631

SN - 9789814411042

SP - 129

EP - 151

BT - Nanotechnology for the Delivery of Therapeutic Nucleic Acids

PB - Pan Stanford Publishing

ER -